In various reports, neuroleptic malignant syndrome develops in an estimated 0.02 to 3% of patients exposed to an implicated drug, depending on the population studied, the agent, the duration of ...

Neuroleptic malignant syndrome is a neurological condition associated with the use of antipsychotic medications. Learn about its symptoms, causes, and more.

A new study in the Journal of Child and Adolescent Psychopharmacology estimates the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic treatment ...

A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of ...

Lane’s death was deemed natural by the county coroner’s office and is officially listed as Neuroleptic Malignant Syndrome. NMS is a known, but rare, side effect of anti-psychotic medications.

Ray, W. A., et al. (2024). Incidence of Neuroleptic Malignant Syndrome During Antipsychotic Treatment in Children and Youth: A National Cohort Study. Journal of Child and Adolescent ...

A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of ...